Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers
의료 종사자에서 비활성화된 COVID-19 백신의 안전성 및 면역원성
Article
[키워드] administration
adverse event
Adverse reaction
Adverse reactions
age
antibodies
antibody
Antibody Response
Antibody responses
appear
booster doses
comparable
Concentration
conducted
convalescent plasma
convalescent serum
CoronaVac
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 vaccine
domain
dose
Effective vaccines
geometric mean
geometric mean concentration
GMC
Health care
Health care worker
health care workers
hospital
IgG
immunization
immunogenicity
Immunoglobulin
Immunoglobulin G
inactivated
Inactivated vaccine
incidence
Infection
injection
Injection-site pain
Local
myalgia
N protein
nucleocapsid
nucleocapsid protein
Pain
pandemic
participant
positive
prospective cohort study
Protein
RBD
Receptor-binding domain
recruited
regimen
Safe
Safety
SARS-CoV-2
Serious Adverse Event
Serious Adverse Events
seroconversion rate
seroconversion rates
Spike protein
tested
the RBD
Total
total antibodies
total antibody
U/mL
Vaccine
virus
waned
[DOI] 10.1002/jmv.27458 PMC 바로가기 [Article Type] Article
[DOI] 10.1002/jmv.27458 PMC 바로가기 [Article Type] Article